Showing results (231-240 of 309) with videos related to
Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
Device-Assisted Therapy in Non-Muscle-Invasive Bladder CancerSandeep Gurram, Nityam RathiBladder Cancer (Amsterdam, Netherlands)|November 4, 2024
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder CancerJoep J de Jong, Florus C de Jong, Angelique C J van der Made, et al.Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.Bladder Cancer (Amsterdam, Netherlands)|January 17, 2020
MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising RadiationAlexandra K Walker, Juri Na, Lisa Browning, et al.Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 YearsDerek RaghavanBladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder CancerRyan L Steinberg, Lewis J Thomas, Michael A O'Donnell, et al.Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Immunotherapy and Radiation - A New Combined Treatment Approach for Bladder Cancer?Zachary S Buchwald, Jason A EfstathiouBladder Cancer (Amsterdam, Netherlands)|September 26, 2022
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and PrognosisAlexandra Masson-Lecomte, Pascale Maillé, Silvia Pineda, et al.Bladder Cancer (Amsterdam, Netherlands)|May 17, 2021
Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerBladder Cancer (Amsterdam, Netherlands)|June 7, 2021
Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future DirectionsKyle B Zuniga, Rebecca E Graff, David B Feiger, et al.Pageof 31